Method for modifying or regulating lipid metalolism in an animal or human subject with a proclactin stimulating compound

US5688794A · kind A · utility

Assignees

• Ergo Science Incorporated · US
• BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE · US

Inventors

• Albert H. Meier · Baton Rouge, US
• Anthony H. Cincotta · Baton Rouge, US

Key dates

• Filing date: Oct 31, 1995
• Grant date: Nov 18, 1997
• Expiry date: Oct 31, 2015

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S436/811
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A process for the long term modification and regulation of lipid and glucose metabolism--generally to reduce obesity, insulin resistance, and hyperinsulinemia or hyperglycemia, or both (these being the hallmarks of non-insulin dependent, or Type II diabetes)--by administration to a vertebrate, animal or human, or a prolactin stimulating compound.